These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7517766)

  • 21. Immunoglobulin G response of periodontitis patients to Porphyromonas gingivalis capsular carbohydrate and lipopolysaccharide antigens.
    Sims TJ; Schifferle RE; Ali RW; Skaug N; Page RC
    Oral Microbiol Immunol; 2001 Aug; 16(4):193-201. PubMed ID: 11442843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological relationships between Escherichia coli and Salmonella smooth- and rough-mutant lipopolysaccharides as revealed by enzyme-linked immunosorbent assay for human immunoglobulin G antiendotoxin antibodies.
    Barclay GR; Scott BB
    Infect Immun; 1987 Nov; 55(11):2706-14. PubMed ID: 3312008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fimbrial serotypes of Escherichia coli strains isolated from extra-intestinal infections.
    De Ree JM; Van den Bosch JF
    J Med Microbiol; 1989 Jun; 29(2):95-9. PubMed ID: 2471835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipopolysaccharide-Linked Enterobacterial Common Antigen (ECA
    Maciejewska A; Kaszowska M; Jachymek W; Lugowski C; Lukasiewicz J
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
    Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
    J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological characterization of the core region of lipopolysaccharides of rough Proteus sp. strains.
    Palusiak A; Sidorczyk Z
    Arch Immunol Ther Exp (Warsz); 2009; 57(4):303-10. PubMed ID: 19578814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a LPS-based glycoconjugate vaccine against bovine Escherichia coli mastitis: Formation of LPS Abs in cows after immunization with E. coli core oligosaccharides conjugated to hemocyanine.
    Brade L; Hensen S; Brade H
    Innate Immun; 2013; 19(4):368-77. PubMed ID: 23112009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological characterisation of anti-endotoxin sera directed against the conjugates of oligosaccharide core of Escherichia coli type R1, R2, R3, J5 and Salmonella Ra with tetanus toxoid.
    Lugowski C; Jachymek W; Niedziela T; Rowinski S
    FEMS Immunol Med Microbiol; 1996 Nov; 16(1):21-30. PubMed ID: 8954349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides.
    Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB
    J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine monoclonal antibodies against Escherichia coli O4 lipopolysaccharide and H5 flagellin.
    Rivera-Betancourt M; Keen JE
    J Clin Microbiol; 2001 Sep; 39(9):3409-13. PubMed ID: 11526192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The accessibility of cross-reactive anti-lipopolysaccharide-core monoclonal antibodies to Escherichia coli grown in sub-MICs of temocillin and other antibiotics.
    Edmond DM; Poxton IR; di Padova F
    J Antimicrob Chemother; 1993 May; 31(5):673-80. PubMed ID: 8335496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monoclonal antibodies against the capsular K antigen of Escherichia coli (O9:K30(A):H12): characterisation and use in analysis of K antigen organisation on the cell surface.
    Homonylo MK; Wilmot SJ; Lam JS; MacDonald LA; Whitfield C
    Can J Microbiol; 1988 Oct; 34(10):1159-65. PubMed ID: 2461792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Escherichia coli serotyping and disease in man and animals.
    Orskov F; Orskov I
    Can J Microbiol; 1992 Jul; 38(7):699-704. PubMed ID: 1382824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of monoclonal antibodies to O-antigen of lipopolysaccharide of Actinobacillus pleuropneumoniae serotype 2 and their use in the classification of field isolates.
    Rodríguez-Barbosa JI; Gutiérrez CB; Tascón RI; Suárez J; De Noronha F; Rodríguez-Ferri EF
    FEMS Immunol Med Microbiol; 1995 Mar; 11(1):35-44. PubMed ID: 7541271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serological detection of verocytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome in western Europe.
    Chart H; van der Kar NC; Tolboom JJ; Monnens LM; Rowe B
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):707-9. PubMed ID: 7694851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [O- and H-antigens of Escherichia coli K5 isolates in the urine].
    Nimmich W; Zingler G; Falkenhagen U; Naumann G; Kontny I
    Z Urol Nephrol; 1988 Apr; 81(4):257-61. PubMed ID: 2456647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lipopolysaccharide core type of Escherichia coli O157:H7 and other non-O157 verotoxin-producing E. coli.
    Currie CG; Poxton IR
    FEMS Immunol Med Microbiol; 1999 May; 24(1):57-62. PubMed ID: 10340713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The serological response to Verocytotoxigenic Escherichia coli in patients with haemolytic uraemic syndrome.
    Chart H; Perry NT
    Lett Appl Microbiol; 2004; 38(5):351-4. PubMed ID: 15059202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.
    Santos MF; New RR; Andrade GR; Ozaki CY; Sant'Anna OA; Mendonça-Previato L; Trabulsi LR; Domingos MO
    Clin Vaccine Immunol; 2010 Nov; 17(11):1772-80. PubMed ID: 20861324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
    Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.